In vitro proliferation of γδ T cells in response to pamidronate/IL-2
. | Healthy donors (%) . | All patients (%) . | MM (%) . | NHL (%) . | B-CLL (%) . |
|---|---|---|---|---|---|
| Positive | 14/16 (88) | 20/41 (49) | 12/26 (46) | 8/10 (80) | 1/5 (20) |
| Negative | 2/16 (12) | 21/41 (51) | 14/26 (54) | 2/10 (20) | 4/5 (80) |
. | Healthy donors (%) . | All patients (%) . | MM (%) . | NHL (%) . | B-CLL (%) . |
|---|---|---|---|---|---|
| Positive | 14/16 (88) | 20/41 (49) | 12/26 (46) | 8/10 (80) | 1/5 (20) |
| Negative | 2/16 (12) | 21/41 (51) | 14/26 (54) | 2/10 (20) | 4/5 (80) |